Vinge advises Gränges in conjunction with acquisition of Aluminium Konin

Vinge has advised Gränges AB (publ) in connection with the acquisition of Aluminium Konin, a Polish aluminium manufacturer, for SEK 2.3 billion from Boryszew Group. In connection with the transaction, Gränges intends to perform a rights issue for SEK 2 billion. In order to finance the acquisition, Gränges has entered into a bridge financing facility agreement with certain Nordic banks for SEK 2.3 billion.

Vinge assists Lantmännen in connection with issue of subordinated debentures

Lantmännen co operative association has published a prospectus in relation to an offer to subscribe for subordinated debentures.

Vinge represented sellers when Polhem acquired shares in Solör

Vinge represented the sellers Meritor, Inc. Retirement Plan, Sunrise BE I, LLC and YRC Worldwide, Inc. Master Pension Plans Trust in their divestment of shares in Solör Bioenergi Holding AB (”Solör”) to Polhem Infra KB (”Polhem”).

Vinge advises property company Hembla in connection with Vonovia’s mandatory cash offer

On 7 November 2019, Vonovia SE announced, through its indirectly wholly-owned subsidiary HomeStar InvestCo AB, a mandatory cash offer to the shareholders of Hembla AB (publ) to acquire all shares in Hembla.

Vinge advises SBB on its offer for Hemfosa

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) has announced a recommended public offer to the shareholders of Hemfosa Fastigheter AB (publ) (“Hemfosa”) to tender all their shares in Hemfosa to SBB.

Vinge advises Irisity in connection with a directed new share issue

Vinge is advising Irisity in connection with a directed new share issue of 4,094,000 shares whereby Irisity acquires approximately SEK 35 million.

Vinge has advised SEB in connection with the issuance of Additional Tier 1 Capital of USD 900 million

Vinge has advised Skandinaviska Enskilda Banken AB (publ) as to Swedish law in connection with the issuance of Additional Tier 1 Capital (AT1) of USD 900 million to optimise its capital structure.

Vinge has advised Vicore Pharma in connection with a directed share issue of approximately SEK 125 million

Vinge has advised Vicore Pharma, a Swedish rare disease company focused on interstitial lung diseases and related indications, in connection with a directed share issue whereby Vicore Pharma will receive approximately SEK 125 million in issue proceeds.

Vinge has acted as a Swedish local counsel to Krogerus in advising Caverion Oyj

Vinge has acted as a Swedish local counsel to Krogerus in advising Caverion Oyj, one of the Europe's leading provider of technical solutions for buildings and industries, on its acquisition of Huurre Finland Oy, including its subsidiary Huurre Sweden AB.

Vinge advises Safeture in connection with the offer from Adma

Adma Förvaltnings AB has announced a public cash offer to the shareholders of Safeture AB (publ) to acquire all shares in Safeture.

Vinge has advised Pandox in connection with a directed share issue of approximately SEK 3 billion

Vinge has advised the hotel property owner Pandox in connection with a directed share issue of 16,350,000 class B shares, whereby Pandox will receive approximately SEK 3 billion in issue proceeds.

Vinge represents Arthur J. Gallagher in the acquisition of the insurance intermediary Proinova

Arthur J. Gallagher & Co. has acquired the insurance intermediary Proinova as a part of the strategic development and expansion in Scandinavia.

Vinge has advised Aprea Therapeutics in connection with its listing on Nasdaq, New York

Vinge has advised Aprea Therapeutics, Inc. and its subsidiary Aprea Therapeutics AB in connection with its listing on Nasdaq, New York.

Vinge advises FJ Dynamics on its acquisition of Sveaverken Svea Agri

Vinge has advised FJ Dynamics, a leading global robotic company in the agricultural sector, in connection with its acquisition of Sveaverken Svea Agri.

Vinge advises on the sale of Väggmaterial to Volati

Vinge has advised in connection with the sale of all of the shares in Väggmaterial i Sverige AB to Volati JBF AB.